<DOC>
	<DOC>NCT01333540</DOC>
	<brief_summary>A dose-escalation study to assess the safety, tolerability and clinical activity of TD−1211 in patients with opioid-induced constipation.</brief_summary>
	<brief_title>A Study to Assess the Safety, Tolerability and Clinical Activity of TD−1211 in Patients With Opioid-Induced Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<criteria>Males and females between 18 and 65 years of age, inclusive Subjects with documented OIC on stable opioid regimen Willingness to stop all laxatives throughout runin and treatment period Any clinically significant findings in subjects with OIC Have participated in another clinical trial of an investigational drug 30 days prior to screening History of chronic constipation prior to opioid therapy in OIC subjects Active medical disorders associated with diarrhea or intermittent loose stools in OIC subjects</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>constipation</keyword>
	<keyword>opioid induced</keyword>
</DOC>